Detection and false-positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages

Prenatal Diagnosis

Volumn 22, Issue 5, 2002, Pages 350-353

  Muller, Franoise ^a,e   Thalabard, Jean Christophe ^a   Ngo, Sandrine ^b,c   Dommergues, Marc ^c,d  

^a Hpital Ambroise Par AP HP   (France)

^b Hpital Necker Enfants Malades AP HP   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Biochimie   (France)

Author keywords

Down syndrome; Maternal serum screening; Prenatal screening; Risk calculation; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; ASSAY; CALCULATION; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; DOWN SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PATIENT COUNSELING; PRENATAL SCREENING; PRIORITY JOURNAL; RISK; SECOND TRIMESTER PREGNANCY; SIMULATION; TRISOMY 21;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COMPUTER SIMULATION; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SOFTWARE;

EID: 0036106426     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.292     Document Type: Article

References (18)

1. Bias, prevalence and kappa
2. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis
3. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age
4. The measurement of interrates agrement
5. Prenatal screening for Down syndrome with use of maternal serum markers
6. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening
7. Measurement of choriogonadotropin free beta subunit: An alternative to choriogonadotropin in screening for fetal Down's syndrome?
8. Prospective maternal serum human chorionic gonadotrophin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths
9. Software for prenatal Down syndrome risk calculation: A comparative study of six software packages
10. Maternal serum screening for Down syndrome in the United States: A 1995 survey
11. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG and unconjugated estriol. A prospective two-year study
12. Prenatal detection of trisomy 21: Combined experience of two British hospitals
13. Fetal loss rate after second trimester amniocentesis at different gestational age
14. Down syndrome prevention program in a population with an older maternal age
15. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
16. Maternal serum screening for Down's syndrome in early pregnancy
17. Antenatal screening for Down's syndrome